NASP Comments to CMS on Part B Drug Proposal

NASP comments on the organization’s concerns over the CMS proposed plan.

©2016 National Association of Specialty Pharmacy
1800 Diagonal Road, Suite 600
Alexandria, VA 22314
703.842.0122